Novartis AG vs Williams-Sonoma, Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Williams-Sonoma, Inc. trades at $223.2 (market cap $26.30B). The key difference: Novartis AG is far larger — about 11× Williams-Sonoma, Inc.'s market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | WSM | |
|---|---|---|
Market Cap | $290.25B | $26.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $240.06 |
52-Week Low | $113.50 | $168.64 |
Enterprise Value | $330.27B | $27.14B |
Dividend Yield | 3.17% | 1.36% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →